Caladrius Biosciences, Inc. (NASDAQ: LSTA) reported Q2 EPS of ($0.54), $0.10 better than the analyst estimate of ($0.64).

For earnings history and earnings-related data on Caladrius Biosciences, Inc. (LSTA) click here.